Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors

CONCLUSIONS: Genetic and clinical characteristics were predictive of higher CIPN symptomatology in gynecologic cancer survivors, and combining these factors resulted in superior predictive power compared with a model with clinical factors only. Prospective validation and assessment of clinical utility are warranted.PMID:34674889 | DOI:10.1016/j.ygyno.2021.10.006

Source: Gynecologic Oncology - October 22, 2021 Category: Cancer & Oncology Authors: Lauren Thomaier Burcu F Darst Patricia Jewett Cody Hoffmann Katherine Brown Aditi Makaram Anne Blaes Peter Argenta Deanna Teoh Rachel I Vogel Source Type: research